It is the best of times; It is the worst of times: Is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues

Research output: Contribution to journalEditorial

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)3884-3886
Number of pages3
JournalArthritis and rheumatism
Volume56
Issue number12
DOIs
StatePublished - Dec 1 2007

Fingerprint

Antirheumatic Agents
Cost-Benefit Analysis
Rheumatoid Arthritis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Cite this

@article{ffca71593ef84054b7e103d14c41f691,
title = "It is the best of times; It is the worst of times: Is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues",
author = "O'Dell, {James Robert}",
year = "2007",
month = "12",
day = "1",
doi = "10.1002/art.23140",
language = "English (US)",
volume = "56",
pages = "3884--3886",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "12",

}

TY - JOUR

T1 - It is the best of times; It is the worst of times

T2 - Is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues

AU - O'Dell, James Robert

PY - 2007/12/1

Y1 - 2007/12/1

UR - http://www.scopus.com/inward/record.url?scp=37149040084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37149040084&partnerID=8YFLogxK

U2 - 10.1002/art.23140

DO - 10.1002/art.23140

M3 - Editorial

C2 - 18050217

AN - SCOPUS:37149040084

VL - 56

SP - 3884

EP - 3886

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 12

ER -